Daniel J. Mazanec, MD Director, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic
Vinod K. Podichetty, MD Coordinator, Research Studies, Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic
Alex Mompoint, MD Spine Center, Department of Physical Medicine and Rehabilitation, The Cleveland Clinic
Amarish Potnis, MD Telemark Physical Medicine, Greenville, PA
Address: Daniel J. Mazanec, MD, Director, Spine Center, Rheumatologic & Immunologic Disease, C21, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mazaned@ccf.org
This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTNew drugs to treat osteoporosis, along with two new minimally invasive surgical procedures, are important options for preventing vertebral compression fractures and treating severe back pain and disability. However, the mainstay treatments remain cautious use of analgesics, limited bed rest, and physical rehabilitation.
